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Problem: Perturbations in normal fetal growth during pregnancy are associated with 
poor child and adult health outcomes. Inflammation and oxidative stress are recog-
nized as important mechanisms in preeclampsia and preterm birth but have been 
examined less in relation to fetal growth. We hypothesized that maternal inflamma-
tion and oxidative stress in pregnancy would be associated with reduced fetal growth 
and sought to identify windows of vulnerability.
Method of study: In a secondary analysis of 482 women from the LIFECODES birth 
cohort study, we measured inflammation (C- reactive protein [CRP] and the cytokines 
IL- 1β,	 IL-	6,	 IL-	10,	 and	 TNF-	α) and oxidative stress (8- isoprostane and 
8- hydroxydeoxyguanosine [8- OHdG]) biomarkers in plasma and urine, respectively, 
at four time points during pregnancy. We examined associations between repeated 
measures of each marker and ultrasound (head and abdominal circumference, femur 
length, and a summary measure of estimated fetal weight) as well as delivery (birth-
weight) metrics of growth.
Results: In adjusted repeated- measures models, an interquartile range (IQR) increase 
in CRP was associated with a 0.12 standard deviation decrease in fetal weight z- score 
(95%	confidence	interval,	CI,	−0.21,	−0.02),	which	corresponds	to	approximately	50	g	
at 40- week gestation. The association was greatest in magnitude (ie, most negative) 
with CRP measured later in pregnancy. Oxidative stress markers were not associated 
with fetal weight, although both were inversely associated with head circumference 
and femur length.
Conclusion: Inflammation and oxidative stress markers measured later in pregnancy 
were associated with reduced fetal growth as measured by repeated ultrasound 
scans.
K E Y W O R D S
biomarkers, birthweight, circulation, cytokines, inflammation, intrauterine growth restriction, 
isoprostane
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1  | INTRODUC TION
Intrauterine growth restriction is a serious complication of pregnancy 
that is a major predictor of neonatal mortality and morbidities.1 
Decreased weight for gestational age at birth, which comprises nor-
mal as well as pathologic variation, is associated with consequences 
that last into childhood and even adult life.2,3 Known contributors 
to pathologic fetal growth restriction include congenital anomalies 
and extreme maternal dietary restriction. However, numerous other 
factors can alter implantation and development of the placenta, hor-
mone transfer to the fetus, and supply and demand of nutrients that 
can adversely affect growth.
Maternal infection with diseases like malaria, which is character-
ized by activation of inflammation and oxidative stress pathways, is 
strongly associated with fetal growth restriction.4 However, the im-
pact of elevated but subclinical levels of inflammation and oxidative 
stress is less well known. Data from animal and cellular models sug-
gest that inflammation and oxidative stress early in pregnancy can 
interfere with normal placentation, namely by inducing apoptosis of 
the syncytiotrophoblast and impairing invasion of the spiral arteri-
oles.5 Studies in humans, however, are limited by the availability of 
biomarker measurements from single time points during gestation or 
the use of birthweight alone as a proxy for growth.6-14
In this study, we sought to address whether maternal inflam-
mation and oxidative stress biomarker concentrations measured 
longitudinally across pregnancy were associated with repeated ul-
trasound	as	well	as	delivery	measures	of	fetal	growth.	Additionally,	
we examined whether associations between biomarkers and growth 
differed depending on when they were measured during pregnancy, 
what parameter was used to assess growth (eg, weight or head cir-
cumference), and sex of the fetus.
2  | MATERIAL S AND METHODS
2.1 | Study population
LIFECODES is an ongoing prospective birth cohort conducted at 
Brigham	and	Women’s	Hospital	(BWH)	in	Boston,	MA.	Women	are	
recruited	early	in	gestation	(prior	to	15	weeks)	and	provide	repeated	
biological specimens at up to four study visits. Recruitment has been 
ongoing	since	2006.	For	the	present	analysis,	we	 included	women	
who were part of a nested case- control study of preterm birth that 
was originally designed to assess the relationship between phtha-
late exposure and prematurity in pregnancy, and to investigate lon-
gitudinal biomarkers of oxidative stress and inflammation that were 
hypothesized to mediate that assocation.15,16 This study comprised 
all cases of preterm birth (defined as delivery prior to 37- week ges-
tation;	n	=	130)	as	well	as	3:1	randomly	selected	controls	 (n	=	352)	
who	delivered	between	2006	and	2008.17 The present secondary 
analysis leveraged this existing data, which, to our knowledge, are 
not available in any other epidemiologic study, to investigate the re-
lationship between inflammation and oxidative stress biomarkers in 
pregnancy and fetal growth. Unadjusted analysis within the case- 
control population would bias effect estimates, as biomarkers are el-
evated in cases of preterm birth and babies born preterm are smaller 
and in many cases growth- restricted. Thus, we applied inverse 
probability weights to all analyses to account for the case- control 
study design.18 This approach effectively downweights associations 
observed between biomarkers and growth parameters in cases of 
preterm to the proportion at which they would be observed in the 
base	LIFECODES	population	(ie,	12%)	and	ensures	that	the	results	
from this analysis are generalizable.
2.2 | Inflammation and oxidative stress biomarkers
Urine and plasma samples were collected at enrollment (median 
10	weeks),	 and	 at	 three	 subsequent	 visits	 (median	 18,	 26,	 and	
35	weeks).	In	urine,	we	measured	two	biomarkers	of	oxidative	stress	
in each sample: total 8- isoprostane, an indicator of lipid peroxida-
tion; and 8- hydroxydeoxyguanosine (8- OHdG), an indicator of oxida-
tive	DNA	damage.	For	8-	isoprostane,	samples	underwent	an	affinity	
purification step. Concentrations of both analytes were measured 
using	enzyme	immunoassay.	All	analyses	were	performed	at	Cayman	
Chemical	 (Ann	Arbor,	MI,	USA)	 using	methods	 described	 in	 detail	
elsewhere.15 To adjust for urine dilution, specific gravity was meas-
ured	by	a	handheld	refractometer	(Atago	Co.,	Ltd.,	Tokyo,	Japan).
To assess inflammation, we measured C- reactive protein (CRP) 
using enzyme immunoassay, and a panel of cytokines (IL- β,	IL-	6,	IL-	10,	
and TNF- α)	using	a	Milliplex	MAP	High	Sensitivity	Human	Cytokine	
Magnetic Bead Panel (EMD Millipore Corporation, St. Charles, 
MO,	USA).	All	 inflammation	markers	were	measured	 in	 plasma	by	
the	Cancer	Center	 Immunology	Core	 (University	of	Michigan,	Ann	
Arbor,	MI,	USA),	with	methods	described	elsewhere	as	well.16
Oxidative stress and inflammation markers measured in this 
study population showed good reliability over the course of preg-
nancy	 (intraclass	 correlation	 coefficients	 ranging	 from	 0.60	 to	
0.81	for	inflammation	markers	and	0.32	and	0.60	for	8-	OHdG	and	
8- isoprostane, respectively).15,16 Thus, we utilized a last observation 
carried forward approach to impute biomarker measurements miss-
ing	from	each	time	point	as	follows.	Across	all	four	collection	times,	
250	 (13%)	 of	 8-	OHdG	 or	 8-	isoprostane	 measures	 were	 missing,	
while	343	(17.8%)	of	inflammation	biomarkers	were	missing	because	
samples were not provided by participants at those respective vis-
its.	Most	missing	measures,	220	(88%)	for	oxidative	stress	and	245	
(71%)	 for	 inflammation,	were	 imputable	by	 levels	measured	at	 the	
previous visit. The remaining 30 missing oxidative stress measures 
and 88 missing inflammation measures were imputed using mea-
sures from 2 or more visits prior to the index visit. This resulted in 
250	oxidative	stress	biomarker	 imputations:	61	(13%)	at	visit	2;	73	
(15%)	at	visit	3;	and	108	(22%)	at	visit	4.	Likewise,	333	inflammation	
measurements	were	 imputed:	72	 (15%)	at	visit	2;	93	 (19%)	at	visit	
3;	 and	103	 (21%)	 at	 visit	 4.	Additionally,	 since	no	biomarker	mea-
surements were examined at delivery, we used the latest biomarker 
measure	available	(visit	3	or	4	for	95%	of	participants)	to	represent	
levels at that time point for analysis.
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Distributions of all inflammation and oxidative stress mark-
ers were right- skewed and natural- log transformed for statistical 
analyses.
2.3 | Measures of fetal growth
Gestational age for the LIFECODES study is assessed by last men-
strual period with verification by crown- rump length (median 
10 weeks) ultrasound.19 In addition to the gestational dating ultra-
sound, a second trimester (median 18 weeks) morphology ultra-
sound is performed on all patients at BWH to screen for congenital 
abnormalities. Information on head circumference, abdominal cir-
cumference, and femur length is abstracted from this scan. For many 
patients, ultrasound scans are performed at additional time points 
later in pregnancy, either due to obstetrical indications as deter-
mined by the provider or at the request of the patient. For this study 
population, we estimated growth using all ultrasound parameters 
measured after the 18- week morphology screening ultrasound, as 
that time point has been shown to have low variability in individual 
parameters in this and other study populations.20,21
Thus, for the present analysis we included anthropometric ultra-
sound measurements that were performed closest in time to study 
visits	3	and	4	 (median	26	and	35	weeks	gestation).	Measurements	
included head circumference, abdominal circumference, and femur 
length, and we calculated a summary measure of estimated fetal 
weight using the formula of Hadlock22	for	326	participants.	Two	ul-
trasound measurements were available for 148 participants and the 
remaining	had	one	measurement	available.	All	ultrasound	parame-
ters were converted to gestational- age- specific z- scores based on 
mean and standard deviation values obtained from approximately 
19,000	pregnancies	at	BWH	between	2006-	2012.23 Estimated fetal 
weight z- scores were based on estimated fetal weight means and 
standard deviations from that study population as well. In addition to 
ultrasound parameters, we calculated birthweight z- scores based on 
birthweight means and standard deviations from the same reference 
population for all 482 study participants.
2.4 | Model selection and statistical analysis
All	 analyses	 conducted	 in	 SAS	 version	 9.4	 (Cary,	 NC,	 USA).	
Demographic characteristics of the study population were tabu-
lated with weighted percentages. Linear mixed models (LMMs) were 
used to assess associations between repeated measures of log- 
transformed oxidative stress and inflammation biomarkers and each 
z-	scored	measure	of	fetal	size	using	SAS	Proc	Mixed.	These	power-
ful models allow incorporation of multiple measures of exposure (ie, 
inflammation or oxidative stress biomarker) and outcome (ie, growth 
measurement) available on the same participant. Models for head 
circumference, abdominal circumference, and femur length included 
z- scores from ultrasound measurements at visits 3 and 4. Models of 
weight combined the estimated fetal weight z- scores from visits 3 




26-	 and	35-	week	gestation	 and	 imputed	at	delivery,	 in	 relation	 to	
estimated	fetal	weight	z-	scores	from	26-	and	35-	week	gestation	and	
birthweight z-	score	at	delivery.	All	models	included	a	random	inter-
cept for participant and random slope for gestational age at the time 
of measurement (ie, at ultrasound scan or delivery).
Sex, gestational age at the time of size measurement, and ma-
ternal age and race/ethnicity were included in models a priori. 
Additional	covariates	examined	included:	physician-	recorded	mater-
nal body mass index (BMI) at enrollment (examined both continu-
ously and as a categorical variable), education level, health insurance 
provider, any tobacco or alcohol use during pregnancy, parity, use 
of assisted reproductive technology, and use of in vitro fertilization 
TABLE  1 Weighted percentages of characteristics of the study 
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specifically. Covariates were included in final models if they im-
proved	model	fit,	as	assessed	by	Akaike	Information	Criterion	values	
and likelihood ratio tests. In addition to a priori covariates, all final 
models	were	adjusted	 for	maternal	BMI	at	enrollment	 (<25	kg/m2, 
25-	30	kg/m2, >30 kg/m2) and education level (high school, technical 
school, some college, college graduate). Models of oxidative stress 
biomarkers were additionally adjusted for urinary specific gravity 
(time- varying).
In addition to these repeated- measures analyses, we wanted to 
assess windows of vulnerability to oxidative stress and inflammation 
during gestation. To address this question, we examined associa-
tions between biomarker concentrations at each individual visit in 
relation to repeated measures of weight z- scores. Finally, we also 
examined repeated measures of biomarkers in relation to fetal size 
measures stratified by sex in order to investigate any sex differences 
in the associations observed. To test for significance of interactions 
by sex, we extracted P- values from models that included interaction 
terms between sex and each covariate in the model.24
3  | RESULTS
The overall study population (N = 482) was primarily White and 
well- educated (Table 1). Slightly more than half of the babies were 
female	 (55%).	Differences	 in	 birthweight	 z- scores by demographic 
characteristics in this study population have been previously re-
ported.23	 As	 expected,	 birthweight	 z-scores were lower in moth-
ers who self- identified as Black, had lower BMI, had public health 
insurance providers, and who were nulliparous compared to refer-
ence. Unexpectedly, birthweight z- scores were also slightly lower in 
male compared to female fetuses in this study population. Oxidative 
stress and inflammation biomarkers showed moderate to high stabil-
ity in repeated measures across pregnancy, and tended to be higher 
in mothers who were Black, had higher BMI, and who had lower so-
cioeconomic status.15,16
Adjusted	LMMs	showed	that	each	inflammation	biomarker	was	
inversely associated with fetal growth, as indicated by repeated 
z- scores of head circumference, abdominal circumference, femur 
length, and weight; however, few associations reached statistical 
significance (Table 2). The most consistent associations, and the 
effect estimates that were greatest in magnitude, were between 
CRP and growth measurements. For example, an interquartile range 
(IQR) increase in CRP was associated with a 0.12 standard devia-
tion decrease in weight z-	score	(95%	confidence	interval,	CI	=	−0.21,	
−0.02),	which	corresponds	 to	a	decrease	 in	50	grams	at	40	weeks	
gestation (based on mean birthweight at week 40 in the BWH popu-
lation).23	Additionally,	IL-	1β was associated with a 0.08 standard de-
viation	decrease	in	head	circumference	z-	score	(95%	CI=−0.17,	0.00).
To identify windows of vulnerability during pregnancy, we next 
examined models of inflammation biomarkers by visit in relation to 
repeated measures of weight (ie, estimated fetal weight z- scores at 
visits 3 and 4 and birthweight z- score at delivery). For CRP, we ob-
served that associations between levels measured at visits 1 and 2 in 
pregnancy were not associated with weight; however, higher levels 
of CRP measured at visits 3 and particularly at 4 were associated 
with lower weight (Figure 1; effect estimates presented in Table S1). 
This suggests later pregnancy as a potentially vulnerable window 
when higher levels of inflammation could have a greater influence 
on fetal growth. Patterns were similar but less precise for IL- 1β, and 
associations for other cytokines were null (Table S1).
We also investigated whether inflammation marker associations 
with fetal growth differed by sex of the fetus by creating stratified 
models.	Associations	between	CRP	and	weight	were	similar	in	males	
and females (Figure 2; effect estimates presented in Table S2), but 
associations between IL- 1β and weight were inverse for males and 
null for females (P for interaction=0.10). The latter suggests that in-
flammation as indicated by IL- 1β may be have a stronger effect on 
fetal growth in male compared to female fetuses.
In regard to oxidative stress biomarkers, 8- OHdG and 
8- isoprostane were both associated with lower fetal growth, as 
TABLE  2 Adjusteda change in repeatedb z- score measures of fetal growth in association with an interquartile range difference in 
inflammation biomarker from repeated- measures models
Weight (n = 443 subjects, 935 
observations)
Abdominal circumference 
(n = 310 subjects, 467 
observations)
Head circumference (n = 309 
subjects, 464 observations)
Femur length (n = 310 
subjects, 467 observations)
Δ in z- score (95% CI) Δ in z- score (95% CI) Δ in z- score (95% CI) Δ in z- score (95% CI)
CRP −0.12	(−0.21,	−0.02) −0.08	(−0.19,	0.02) −0.09	(−0.19,	0.02) −0.03	(−0.14,	0.09)
IL- 1β −0.05	(−0.14,	0.03) −0.03	(−0.12,	0.06) −0.08	(−0.17,	0.00) −0.04	(−0.13,	0.05)
IL-	6 −0.02	(−0.09,	0.04) −0.01	(−0.09,	0.06) −0.05	(−0.12,	0.02) −0.01	(−0.09,	0.07)
IL- 10 −0.03	(−0.09,	0.04) −0.03	(−0.10,	0.05) −0.03	(−0.10,	0.04) −0.01	(−0.08,	0.07)
TNF- α −0.01	(−0.10,	0.08) 0.04	(−0.06,	0.14) −0.01	(−0.11,	0.09) −0.03	(−0.13,	0.08)
CRP, C- reactive protein.
aAll	associations	modeled	with	random	intercept	for	participant	and	random	slope	for	gestational	age	at	ultrasound	measurement	and	include	fixed	
effects terms for child sex, and maternal age, race, education level, and body mass index at visit 1.
bFor estimated fetal weight, repeated- measures models include measures from ultrasound and delivery. For other parameters, repeated- measures 
models include measures from ultrasound only.
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indicated by each anthropometric measurement; however, the ef-
fect estimates for associations with head circumference and femur 
length were greatest in magnitude (ie, most negative; Table 3). 
An	IQR	increase	in	8-	OHdG	concentration	was	associated	with	a	
0.20 standard deviation decrease in head circumference z- score 
(95%	CI	=	−0.37,	 −0.02).	 For	 8-	isoprostane,	 an	 IQR	 increase	was	




When we examined associations by study visit to investigate 
windows of vulnerability, 8- isoprostane levels measured at visit 3 
were inversely associated with weight and 8- OHdG levels at visit 1 
were positively associated with weight (Figure 1; effect estimates in 
Table S2).
In models stratified by sex, associations were mostly null Figure 2; 
effect estimates presented in Table S2). However, we observed that 
the inverse association between 8- OHdG and weight was stronger 
in females compared to males (P	for	interaction=0.09).
4  | DISCUSSION
Inflammation has long been suspected to play an important role 
in growth restriction and preeclampsia, although support is more 
consistent for the latter.25	Animal	evidence	also	strongly	supports	
a causative relationship between inflammation and reduced fetal 
growth. The largest study in humans to address this research ques-
tion was within the Generation R birth cohort, in which CRP levels 
were measured in the first trimester of pregnancy.7 Increased lev-
els were associated with lower estimated fetal weight, measured by 
ultrasound in the third trimester, and also with lower birthweight.7 
Other cross- sectional studies have similarly observed inverse as-
sociations between CRP, measured at various time points during 
pregnancy, and birthweight.26,27	 Two	 small	 studies	 (N	≤	200)	with	
repeated measures of CRP did not analyze associations by trimes-
ter, but also observed inverse associations with birthweight.6,13 Our 
studies are somewhat consistent with these findings, although we 
observed null associations with CRP measured at ~10 weeks gesta-
tion, and the most precise effect estimates with levels measured at 
F IGURE  1 Assessing	Windows	of	Vulnerability	During	Pregnancy:	Adjusteda Change in Repeated Weight z- Score Measures in 
Association	with	an	Interquartile	Range	Difference	in	Oxidative	Stress	or	Inflammation	Biomarker	Measurement	in	Models	Stratified	by	Visit	
of Sample Collection. aAll	associations	modeled	with	random	intercept	for	participant	and	random	slope	for	gestational	age	at	ultrasound	
measurement and include fixed effects terms for visit- specific urinary specific gravity (8- OHdG and 8- isoprostane models only), child sex, 
and	maternal	age,	race,	education	level,	and	body	mass	index	at	visit	1.	Abbreviations:	8-	OHdG,	8-	hydroxydeoxyguanosine;	CRP,	C-	reactive	
protein
F IGURE  2 Assessing	Sex	Differences	in	Associations:	Adjusteda Change in Repeated Weight z-	Score	Measures	in	Association	with	an	
Interquartile Range Difference in Repeated Measures of Oxidative Stress or Inflammation Biomarkers in Models Stratified by Fetal Sex. aAll	
associations modeled with random intercept for participant and random slope for gestational age at ultrasound measurement and include 
fixed effects terms for urinary specific gravity (time- varying, 8- OHdG and 8- isoprostane models only) and maternal age, race, education 
level,	and	body	mass	index	at	visit	1.	Abbreviations:	8-	OHdG,	8-	hydroxydeoxyguanosine;	CRP,	C-	reactive	protein
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~35	weeks	gestation.	These	data	suggest	that	inflammation	later	in	
pregnancy—whether consequence or cause—may be characteristic 
of decreased fetal growth as well.
Few studies have examined cytokines in relation to birthweight 
or fetal growth,8,10 and to our knowledge none has done so with 
repeated biomarkers or ultrasound measurements. Our largely null 
findings for inflammatory cytokines suggest these markers may not 
be useful in the study of fetal growth. This may be due to poor cor-
relation between plasma cytokines and inflammation in the compart-
ment	of	interest	(eg,	placenta	or	fetus).	Additional	work	to	examine	
this question in more detail is warranted.
Oxidative stress is an imbalance between reactive oxygen spe-
cies and antioxidant capacity that may result from or cause inflam-
mation. While an elevation of oxidative stress in early pregnancy 
relative to pre- pregnancy is normal, levels that are too high could 
interfere with normal placentation. Few studies in humans have in-
vestigated associations between prenatal oxidative stress biomark-
ers and fetal growth. Studies measuring 8- OHdG levels in urine 
from early11,12 as well as late9,14 pregnancy have demonstrated as-
sociations with decreased birthweight or increased risk of small for 
gestational age. Our findings are consistent with these data, as we 
observed associations between repeated measures of 8- OHdG over 
pregnancy and decreased head circumference and femur length z- 
scores. Interestingly, the association with weight was strongest in 
girls in our stratified analysis by fetal sex, which was also observed 
by Lindstrom et al.11
Levels of 8- isoprostane in amniotic fluid collected during preg-
nancy have been strongly associated with fetal growth restric-
tion.28 However, the Lindstrom study, which examined urinary 
8- isoprostane concentrations at both 14- and 30- week gestation, 
found no association with birthweight or other metrics at delivery.11 
In fact, they observed that elevated levels early in pregnancy were 
associated with increased weight. We found that 8- isoprostane was 
inversely associated with repeated measures of head circumference 
and	femur	length,	and	that	levels	at	~26	weeks	gestation	were	asso-
ciated with decreased weight. This may suggest that oxidative stress 
levels in pregnancy have a stronger influence on some anthropomet-
ric parameters (eg, head size) compared to others.
Our study of inflammation and oxidative stress markers in re-
lation to fetal growth was limited in part by our study population. 
This was a secondary analysis using existing data from a nested 
case- control study of preterm birth. This population was chosen for 
this analysis because of the availability of the rich set of biomarkers 
of inflammation and oxidative stress. However, it was not designed 
specifically to investigate the associations between these biomark-
ers and fetal growth. Because of inverse probability weights applied 
to all analyses, the results are adjusted for the case- control design 
and the findings do not overly represent associations that are unique 
to cases of preterm birth. The primary limitations of using this study 
population are due to the fact that the ultrasound data utilized in the 
present analysis was collected clinically and not for research pur-
poses.	This	could	limit	the	quality	of	the	data	collected.	Additionally,	
because scans later in pregnancy are more likely to be performed 
among women who are suspected to have pregnancy complications, 
our findings may be characteristic of events occurring in higher risk 
pregnancy.	Also	for	this	reason,	our	sample	size	was	limited	for	anal-
yses examining ultrasound measurements only (head and abdominal 
circumference and femur length). Nevertheless, these data provide 
additional power beyond what we could muster using birth mea-
surements alone. Furthermore, they provide the ability to examine 
individual anthropometric parameters like head circumference and 
femur length, which are rarely captured in these types of studies.
Because of the limited availability of repeat ultrasound measure-
ments in pregnancy, we were unable to capture associations with 
rates of growth during gestation, which may be particularly im-
portant. In our other studies of inflammation and oxidative stress 
measures in relation to preterm birth and preeclampsia we were 
able to separate cases based on presentations that may have more 
homogeneous etiologies (including spontaneous vs placentally me-
diated for preterm birth and early vs late onset for preeclampsia). 
Distinguishing pathologic from normal fetal growth is a more diffi-
cult challenge.
TABLE  3 Adjusteda change in repeatedb z- score measures of fetal growth in association with an interquartile range difference in 
oxidative stress biomarker from repeated- measures models
Fetal weight (n = 448 
subjects, 937 
observations)
Abdominal circumference (n = 314 
subjects, 468 observations)
Head circumference (n = 313 
subjects, 465 observations)
Femur length (n = 314 
subjects, 468 observations)
Δ in z- score (95% CI) Δ in z- score (95% CI) Δ in z- score (95% CI) Δ in z- score (95% CI)
8- OHdG −0.09	(−0.25,	0.06) −0.03	(−0.21,	0.15) −0.20	(−0.37,	−0.02) −0.16	(−0.36,	0.03)
8- isoprostane −0.03	(−0.13,	0.06) −0.07	(−0.18,	0.05) −0.13	(−0.24,	−0.02) −0.13	(−0.24,	−0.01)
8- OHdG, 8- hydroxydeoxyguanosine.
aAll	associations	modeled	with	random	intercept	for	participant	and	random	slope	for	gestational	age	at	ultrasound	measurement	and	include	fixed	
effects terms for urinary specific gravity (time- varying) child sex, and maternal age, race, education level, and body mass index at visit 1.
bFor estimated fetal weight, repeated- measures models include measures from ultrasound and delivery. For other parameters, repeated- measures 
models include measures from ultrasound only.
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This study benefited from the availability of four measurements 
of a panel of both inflammation and oxidative stress measures during 
pregnancy, which allowed us to examine windows during gestation 
when these levels may be particularly influential. We also were able 
to utilize ultrasound measurements of fetal growth, which gave us 
greater power in repeated- measures models and also allowed us to 
identify associations with anthropometric parameters that had not 
been examined in relation to these markers in the past.
In conclusion, we observed inverse associations between CRP 
and fetal weight and between the oxidative stress markers 8- OHdG 
and 8- isoprostane and head circumference and femur length. Effect 
estimates for CRP were strongest (ie, most negative) with levels mea-
sured later in pregnancy, and the same was true for 8- isoprostane. 
This represents the first study to our knowledge to examine associ-
ations between inflammation and oxidative stress biomarkers mea-
sured at multiple time points within the same participants in relation 
to fetal growth. These findings inform not only the understanding 
of biological changes in pregnancy that are related to perturbations 
in fetal growth, but also could help to explain why perturbations in 
fetal growth are linked to consequences in childhood and later in life.
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